Supplementary - Terbinafine Is Not Associated with Increased Rhabdomyolysis Risk Compared with Fluconazole

Name: Supplementary - Terbinafine Is Not Associated with Increased Rhabdomyolysis Risk Compared with Fluconazole
Creator: Rebecca Zhang
Published: 2026-07-12T23:04:12.065Z
Keywords: Pharmacotherapy, Antifungal, Tinea Capitis, Dermatophyte, Onychomycosis, Rhabdomyolysis

Zhang, Rebecca

doi:10.17632/9jsxk26dhk.1

Supplementary - Terbinafine Is Not Associated with Increased Rhabdomyolysis Risk Compared with Fluconazole

Published: 12 July 2026| Version 1 | DOI: 10.17632/9jsxk26dhk.1

Contributor:

Rebecca Zhang

Description

Supplementary data for "Terbinafine Is Not Associated with Increased Rhabdomyolysis Risk Compared with Fluconazole: A TriNetX Analysis"

Supplementary - Terbinafine Is Not Associated with Increased Rhabdomyolysis Risk Compared with Fluconazole

Description

Files

Categories

Licence